421 related articles for article (PubMed ID: 26855010)
21. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung.
Duch MC; Budinger GR; Liang YT; Soberanes S; Urich D; Chiarella SE; Campochiaro LA; Gonzalez A; Chandel NS; Hersam MC; Mutlu GM
Nano Lett; 2011 Dec; 11(12):5201-7. PubMed ID: 22023654
[TBL] [Abstract][Full Text] [Related]
22. Can graphene oxide cause damage to eyesight?
Yan L; Wang Y; Xu X; Zeng C; Hou J; Lin M; Xu J; Sun F; Huang X; Dai L; Lu F; Liu Y
Chem Res Toxicol; 2012 Jun; 25(6):1265-70. PubMed ID: 22587431
[TBL] [Abstract][Full Text] [Related]
23. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power.
Yang K; Wan J; Zhang S; Tian B; Zhang Y; Liu Z
Biomaterials; 2012 Mar; 33(7):2206-14. PubMed ID: 22169821
[TBL] [Abstract][Full Text] [Related]
24. Protein corona mitigates the cytotoxicity of graphene oxide by reducing its physical interaction with cell membrane.
Duan G; Kang SG; Tian X; Garate JA; Zhao L; Ge C; Zhou R
Nanoscale; 2015 Oct; 7(37):15214-24. PubMed ID: 26315610
[TBL] [Abstract][Full Text] [Related]
25. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
[TBL] [Abstract][Full Text] [Related]
26. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
27. Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial.
Zhang XF; Gurunathan S
Int J Nanomedicine; 2016; 11():6635-6649. PubMed ID: 27994461
[TBL] [Abstract][Full Text] [Related]
28. Surface tailoring of polyacrylate-grafted graphene oxide for controlled interactions at the biointerface.
Consiglio G; Di Pietro P; D'Urso L; Forte G; Grasso G; Sgarlata C; Cossement D; Snyders R; Satriano C
J Colloid Interface Sci; 2017 Nov; 506():532-542. PubMed ID: 28756320
[TBL] [Abstract][Full Text] [Related]
29. The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.
Dudek I; Skoda M; Jarosz A; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):195-215. PubMed ID: 26502273
[TBL] [Abstract][Full Text] [Related]
30. Graphene oxide regulates cox2 in human embryonic kidney 293T cells via epigenetic mechanisms: dynamic chromosomal interactions.
Sun Y; Dai H; Chen S; Xu M; Wang X; Zhang Y; Xu S; Xu A; Weng J; Liu S; Wu L
Nanotoxicology; 2018 Mar; 12(2):117-137. PubMed ID: 29338479
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro toxicity of a graphene oxide-silver nanocomposite and the pristine counterparts toward macrophages.
de Luna LA; de Moraes AC; Consonni SR; Pereira CD; Cadore S; Giorgio S; Alves OL
J Nanobiotechnology; 2016 Feb; 14():12. PubMed ID: 26912341
[TBL] [Abstract][Full Text] [Related]
32. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system.
Assali A; Razzazan S; Akhavan O; Mottaghitalab F; Adeli M; Atyabi F
Colloids Surf B Biointerfaces; 2019 Jan; 173():891-898. PubMed ID: 30551306
[TBL] [Abstract][Full Text] [Related]
33. Platelet adhesion and cellular interaction with poly(ethylene oxide) immobilized onto silicone rubber membrane surfaces.
Hsiue GH; Lee SD; Chang PC
J Biomater Sci Polym Ed; 1996; 7(10):839-55. PubMed ID: 8836831
[TBL] [Abstract][Full Text] [Related]
34. L-cysteine: a biocompatible, breathable and beneficial coating for graphene oxide.
Mu L; Gao Y; Hu X
Biomaterials; 2015 Jun; 52():301-11. PubMed ID: 25818436
[TBL] [Abstract][Full Text] [Related]
35. Surface-engineered graphene navigate divergent biological outcomes toward macrophages.
Luo N; Ni D; Yue H; Wei W; Ma G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5239-47. PubMed ID: 25692327
[TBL] [Abstract][Full Text] [Related]
36. The Structure-Properties-Cytotoxicity Interplay: A Crucial Pathway to Determining Graphene Oxide Biocompatibility.
Dziewięcka M; Pawlyta M; Majchrzycki Ł; Balin K; Barteczko S; Czerkawska M; Augustyniak M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065593
[TBL] [Abstract][Full Text] [Related]
37. Investigating oxidation state-induced toxicity of PEGylated graphene oxide in ocular tissue using gene expression profiles.
Wu W; Yan L; Chen S; Li Q; Gu Z; Xu H; Yin ZQ
Nanotoxicology; 2018 Oct; 12(8):819-835. PubMed ID: 29888639
[TBL] [Abstract][Full Text] [Related]
38. In vitro toxicity evaluation of graphene oxide on A549 cells.
Chang Y; Yang ST; Liu JH; Dong E; Wang Y; Cao A; Liu Y; Wang H
Toxicol Lett; 2011 Feb; 200(3):201-10. PubMed ID: 21130147
[TBL] [Abstract][Full Text] [Related]
39. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets.
Zhou T; Zhang B; Wei P; Du Y; Zhou H; Yu M; Yan L; Zhang W; Nie G; Chen C; Tu Y; Wei T
Biomaterials; 2014 Dec; 35(37):9833-9843. PubMed ID: 25212524
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
